Nitric oxide (NO) and an NMDA receptor antagonist in pentylenetetrazole-induced convulsions

Acta Veterinaria

Volumn 53, Issue 2-3, 2003, Pages 103-112

  Jelenković, Ankica ^a,c   Jovanović, Marina ^b   Ninković, Milica ^b   Maksimovic M ^b   Boskovic B ^b  

^a Institute for Biological Research S Stankovi   (Serbia)

^b DEPARTMENT OF TOXICOLOGY   (Czech Republic)

^c UNIVERSITY OF DEFENCE   (Serbia)

Author keywords

Convulsions; Nitric oxide; NMDA antagonists; Pentylenetetrazole; Superoxide anion; Superoxide dismutase

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PENTETRAZOLE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; CONVULSION; DRUG EFFECT; DRUG MECHANISM; DYSTONIA; FOREBRAIN; HIPPOCAMPUS; MALE; METABOLISM; NEUROPROTECTION; NONHUMAN; RAT; STRIATE CORTEX;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0037823473     PISSN: 05678315     EISSN: None     Source Type: Journal    
DOI: 10.2298/avb0303103j     Document Type: Article

References (28)

1. Alexander C, Ellmore T, Kokate T, Kirkby R, 1998, Further studies on anti- and proconvulsant effects of inhibitors of nitric oxide synthase in rodents, Eur J Pharmacol, 344:15-25.
2. Auclair C, Voisin E, 1985, Nitroblue tetrazolium reduction, In: Greenwald RA, editor. Handbook of Methods for Oxygen Radical Research, Boca Raton: CRC Press Inc, 123-32.
3. Beckman JS, 1991, The double-edged role of nitric oxide in brain function and superoxide mediated injury, J Develop Physiol, 15:53-9.
4. Ben-Ari Y, Tremblay D, Riche D, Chilini G, Naquet R, 1981, Electrographic, clinical and pathological alterations following systemic administration of kainic acid, bicuculline and pentetrazole: metabolic mapping using the deoxyglucose, method with special reference to the pathology of epilepsy, Neurosci, 6:1361-91.
5. Crow JP, Beckman JS, 1995, Reactions between nitric oxide, superoxide, and peroxynitrite: footprints of peroxynitrite in vivo. Adv Pharmacol, 34:17-43.
6. Czuczwar S, Tutka P, Klonowski P, Kleinrok Z, 1999, NG-nitro-L-arginine impairs the anticonvulsive action of ethosuximide against pentylenetetrazole, Eur J Pharmacol, 366:137-42.
7. Del-Bel E, Oliveira P, Oliveira J, Mishra P, Jobe P, Garcia-Cairasco N, 1997, Anticonvulsant and proconvulsant roles of nitric oxide in experimental epilepsy models. Braz J Med Biol Res, 30:971-9.
8. Getting SJ, Segieth J, Ahmad S, Biggs CS, Whitton PS, 1996, Biphasic modulation of GABA release by nitric oxide in the hippocampus of freely moving rats in vivo, Brain Res, 717:196-9.
9. Goss SPA, Singh RJ, Hogg N, Kalyanaraman B, 1999, Reactions of NO, NO2 and peroxynitrite in membranes: physiological implications, Free Rad Res, 31:597-606.
10. Gross P, Weaver D, Bowers R, Nag S, Ho L, Pang J, Espinosa F, 1994, Neurotoxicity in conscious rats following intraventricular SNAP, a nitric oxide donor. Neuropharmacol, 7:915-27.
11. Han D, Yamada K, Senzaki K, Xiong H, Nawa H, Nabeshima T, 2000, Involvement of nitric oxide in pentylenetetrazole-induced kindling in rats, J Neurochem, 74:792-8.
12. Hara S, Kuriiwa F, Iwata N, Mukai T, Kano S, Endo T, 1996, Distinct effects of N-omega-nitro-L-arginine on seizures induced by several drugs in mice, Pharmacol Biochem Behav, 53:673-7.
13. Jayakumar A, Sujatha R, Paul V, Puviarasan K, Jayakumar R, 1999, Involvement of nitric oxide and nitric oxide synthase activity in anticonvulsive action, Brain Res Bull, 4:387-94.
14. Jelenković A, Jovanović M, Ninković M, Maksimović M, Bokonjić D, Bošković B, 2002, Nitric oxide (NO) and convulsions induced by pentylenetetrazole, Ann N Y Acad Sci, 296-305.
15. Kohling R, 2002, GABA becomes exciting, Science, 1350-1.
16. Lallement G, Shin T, Pernot-Marino I, Baubichon D, Foquin A, McDonough J, 1996, The role of nitric oxide in soman-induced seizures, neuropathology, and lethality, Pharmacol Bioch Behav, 54:731-7.
17. Michaelis EK, 1998, Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging, Progress Neurobiol, 54:369-415.
18. Mraovitch S, Calando Y, 1999, Interactions between limbic, thalamo-striatal-cortical, and central anatomic pathways during epileptic seizure progression, J Compar Neurol, 411:145-61.
19. Nidhi G, Balakrishnan S, Pandhi P, 1999, Role of nitric oxide in electroshock and pentylenetetrazole seizure threshold in rats, Meth Find Exp Clin Pharmacol, 21:609-12.
20. Ohkuma S, Narihara H, Katsura M, Hasegava T, Kuriyama K, 1995, Nitric oxide-induced 3H release from cortical neurons is mediated by peroxynitrite, J Neurochem, 65:1109-14.
21. Paxinos G, Watson C, 1982, The rat brain stereotaxic coordinates, Acad Pres.
22. Przegalinski E, Baran L, Sianowicz J, 1996, The role of nitric oxide in chemically- and electrically-induced seizures in mice, Neurosci Lett, 217:145-8.
23. Souza MJ, Daikhin E, Yudkoff M, et al., 1999, Factors determining the selectivity of protein tyrosine nitration. Arch Biochem Biophys, 371:169-78.
24. Sun M, Zigman S, 1978, An improved spectrophotometric assay for superoxide dismutase based on epinephrine autooxidation, Anal Biochem, 90: 81-9.
25. Tutka P, Klonowski P, Dzieciuch J, Kleinrok Z, Czuczwar S, 1996, NG-nitro-L-arginine differentially affects glutamate- or kainate-induced seizures. Neuroreport, 7:1605-8.
26. Vega-Agapito V, Almeida A, Heales SJ, Medina JM, Bolanos JP, 1999, Peroxynitrite anion stimulates arginine release from cultured rat astrocytes, J Neurochem, 73:1446-52.
27. Willoughby J. 1999, Epileptogenesis: electrophysiology. In: Eadie M. and Vajda F, editors, Handbook of Experimental Pharmacology, Springer-Verlag, Berlin, Heildeberg, 63-85.
28. Yamada K, Nabeshima T, 1998, Modulation of nitric oxide production in vivo in the brain, Meth Find Exp Clin Pharmacol, 20:601-5.